CSIMarket
 


Dentsply Sirona Inc   (XRAY)
Other Ticker:  
 

Cumulative Dentsply Sirona Inc 's Leverage Ratio for Trailing Twelve Months Period

XRAY's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

XRAY Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -6.72 % -23.48 % -25.21 % -23.71 % -28.62 %
Y / Y Total Liabilities Growth -2.12 % -4.06 % -6.43 % -9.69 % -7.57 %
Leverage Ratio for Trailing Twelve Months Period 1.08 1.06 1 0.94 0.9
Total Ranking # 1844 # 1935 # 1908 # 2111 # 1942
Seq. Equity Growth -8.94 % 1.76 % -4.56 % 5.48 % -25.3 %
Seq. Total Liabilities Growth -2.99 % -2.18 % 5.22 % -1.97 % -4.91 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite debt repayement of -2.99% in III. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 1.08, above Dentsply Sirona Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 130 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Dentsply Sirona Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are XRAY's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 131
Sector # 627
S&P 500 # 1912


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.53 0.86 0.41
(June 30. 2012)   (Mar 31 2017)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Equipment & Supplies Industry Leverage Ratio for Trailing Twelve Months Period
Assure Holdings Corp   2.87 
Marizyme Inc   2.82 
Neuropace Inc   2.72 
Bioventus Inc   2.68 
Cerus Corporation  2.50 
Minerva Surgical Inc   2.46 
Escalon Medical Corp   2.43 
Uphealth Inc   2.41 
Vivos Therapeutics Inc   2.34 
Viewray Inc   2.30 
Plus Therapeutics Inc   2.18 
Tela Bio Inc   2.04 
Vaso Corporation  2.04 
Apollo Endosurgery inc   2.02 
Conmed Corporation  1.94 
Transmedics Group Inc   1.94 
Petvivo Holdings Inc  1.89 
Artivion Inc   1.80 
Dexcom Inc   1.79 
Strata Skin Sciences Inc   1.71 
Msa Safety Incorporated  1.64 
Patterson Companies Inc   1.63 
Pulse Biosciences Inc   1.63 
Iridex Corp  1.62 
Pear Therapeutics Inc   1.59 
Novocure Limited  1.59 
Tandem Diabetes Care Inc   1.48 
Therapeutic Solutions International Inc   1.42 
Orchestra Biomed Holdings Inc   1.40 
Eargo Inc   1.40 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com